Iftekhar Mahmood - Search Results

Year	Number of Results
2002	4
2003	2
2004	3
2005	3
2006	3
2007	3
2008	1
2009	4
2010	4
2011	3
2012	4
2013	4
2014	7
2015	5
2016	6
2017	4
2018	7
2019	5
2020	9
2021	7
2022	0

1

Clinical Pharmacology of Antibody-Drug Conjugates.

Mahmood I. Mahmood I. Antibodies (Basel). 2021 May 21;10(2):20. doi: 10.3390/antib10020020. Antibodies (Basel). 2021. PMID: 34063812 Free PMC article. Review.

2

Dosing Considerations for Antibodies Against COVID-19.

Tegenge MA, Mahmood I, Struble E, Golding B. Tegenge MA, et al. Among authors: mahmood i. Drugs R D. 2021 Mar;21(1):1-8. doi: 10.1007/s40268-020-00330-3. Epub 2020 Dec 1. Drugs R D. 2021. PMID: 33259037 Free PMC article. Review.

3

Considerations for Optimizing Dosing of Immunoglobulins Based on Pharmacokinetic Evidence.

Mahmood I, Tegenge MA, Golding B. Mahmood I, et al. Antibodies (Basel). 2020 Jun 19;9(2):24. doi: 10.3390/antib9020024. Antibodies (Basel). 2020. PMID: 32575458 Free PMC article. Review.

4

Effect of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Antibody-Drug Conjugates (ADCs).

Mahmood I. Mahmood I. Antibodies (Basel). 2021 Oct 15;10(4):40. doi: 10.3390/antib10040040. Antibodies (Basel). 2021. PMID: 34698086 Free PMC article. Review.

5

Interspecies Scaling of Antibody-Drug Conjugates (ADC) for the Prediction of Human Clearance.

Mahmood I. Mahmood I. Antibodies (Basel). 2021 Jan 7;10(1):1. doi: 10.3390/antib10010001. Antibodies (Basel). 2021. PMID: 33430196 Free PMC article.

6

Misconceptions and issues regarding allometric scaling during the drug development process.

Mahmood I. Mahmood I. Expert Opin Drug Metab Toxicol. 2018 Aug;14(8):843-854. doi: 10.1080/17425255.2018.1499725. Epub 2018 Jul 19. Expert Opin Drug Metab Toxicol. 2018. PMID: 29999428 Review.

7

Prediction of drug clearance in children: a review of different methodologies.

Mahmood I. Mahmood I. Expert Opin Drug Metab Toxicol. 2015 Apr;11(4):573-87. doi: 10.1517/17425255.2015.1019463. Epub 2015 Mar 4. Expert Opin Drug Metab Toxicol. 2015. PMID: 25740388 Review.

8

Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Peptides: When Is the Assessment of Certain Factors Warranted?

Mahmood I, Pettinato M. Mahmood I, et al. Antibodies (Basel). 2021 Dec 21;11(1):1. doi: 10.3390/antib11010001. Antibodies (Basel). 2021. PMID: 35076485 Free PMC article. Review.

9

Spreadsheet-Based Minimal Physiological Models for the Prediction of Clearance of Therapeutic Proteins in Pediatric Patients.

Mahmood I, Tegenge MA. Mahmood I, et al. J Clin Pharmacol. 2021 Jun;61 Suppl 1:S108-S116. doi: 10.1002/jcph.1846. J Clin Pharmacol. 2021. PMID: 34185903

10

Pharmacokinetic Considerations in Designing Pediatric Studies of Proteins, Antibodies, and Plasma-Derived Products.

Mahmood I. Mahmood I. Am J Ther. 2016 Jul-Aug;23(4):e1043-56. doi: 10.1097/01.mjt.0000489921.28180.b9. Am J Ther. 2016. PMID: 27386959 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results